Beckman Coulter Licenses Johns Hopkins Cancer IP for Dx Development

Oct 30, 2007

NEW YORK (GenomeWeb News) — Beckman Coulter has inked two deals with Johns Hopkins University for exclusive licenses to intellectual property tied to cancer genomics research, the company said today.

Terms of the agreements give Beckman Coulter the “exclusive option to license any of the genetic mutations discovered in these studies that have diagnostic potential,” Bruce Wallace, vice president of Beckman Coulter's Molecular Diagnostics Business Center, said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Better Recovery

A University of California, Los Angeles-led team has found turning off the CCR5 gene could improve recovery after a stroke, according to Scientific American.

Science 'Critical Thinking' Bill in South Dakota

South Dakota lawmakers are to weigh a bill aimed at teaching the strengths and weaknesses of scientific concepts, the Associated Press and KEVN-Black Hills Fox report.

This Week in Science

In Science this week: the synthetic genetic system hachimoji, and more.

No More

Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.

Main menu